Showing results (51-60 of 358) with videos related to
Sort By:
Pageof 36
British Journal of Haematology|November 8, 2011
Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formationDavid W Scott, Jay N LozierBlood|March 17, 2005
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteinsTie Chi Lei, David W ScottNature Reviews. Cancer|July 11, 2014
The tumour microenvironment in B cell lymphomasDavid W Scott, Randy D GascoyneBest Practice & Research. Clinical Haematology|September 15, 2018
Dissecting aggressive B-cell lymphoma through genomic analysis - What is clinically relevant?David W Scott, Lisa M RimszaFrontiers in Immunology|February 4, 2020
Factor VIII: Perspectives on Immunogenicity and Tolerogenic StrategiesDavid W Scott, Kathleen P PrattCancer Discovery|April 1, 2022
Harnessing Mitochondrial Mutations to ATAC Clonal Evolution in CLLLaura K Hilton, David W ScottCellular Immunology|July 25, 2006
Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cellsNadejda Soukhareva, Yufei Jiang, David W ScottTrends in Immunology|October 30, 2007
Immunogenicity of protein therapeuticsAnne S De Groot, David W ScottDiscovery Medicine|June 4, 2013
Tolerance induction in hemophilia A animal models: battling inhibitors with antigen-specific immunotherapiesPatrick Adair, Yan Su, David W ScottBlood|August 23, 2007
Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytesDirk Brenner, Alexander Golks, Mareike Becker, et al.Pageof 36